Clinical Trial Update: Safety and Efficacy of OMS302 in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR) [Phase 2]

View source ↗

Summary

Phase 2 trial update showing safety and efficacy results for OMS-302 in subjects undergoing unilateral cataract extraction with lens replacement; results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• OMS-302

Snippet

Sponsor: Omeros Corporation | Conditions: Cataract | Phase 2 | Status: COMPLETED | Results posted: 2014-08-28